GlassScriptPhysician profile
Bilal Saqi
NPI 1952752412
$44,141.02
in general payments reported to CMS, 2019-2025
24 companies · $2,245 in 2025
The $2,245 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $281 · 2021: $6,695 · 2022: $11K · 2023: $21K · 2024: $2,759 · 2025: $2,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $14K · Travel and Lodging: $6,517 · Food and Beverage: $5,571 · Education: $78.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $14,000.00 |
| Travel and Lodging | $6,517.10 |
| Food and Beverage | $5,570.58 |
| Education | $78.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,287.47 | 2019-2025 | Ensite Precision, Advisor, Ensite |
| Boston Scientific Corporation | $9,965.87 | 2021-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $6,178.59 | 2022-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Biotronik INC. | $4,006.80 | 2021-2022 | |
| Biosense Webster, INC. | $2,278.85 | 2024-2025 | Carto 3, Octaray Mapping Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $258.67 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $217.66 | 2019-2020 | |
| Astellas Pharma US INC | $194.99 | 2022 | |
| Abiomed | $132.87 | 2019-2025 | |
| Esperion Therapeutics, INC. | $123.00 | 2020 | |
| Merck Sharp & Dohme LLC | $82.99 | 2024-2025 | Verquvo |
| Innovation Technologies INC | $62.99 | 2025 | Irrisept |
| Pfizer INC. | $52.50 | 2025 | |
| Baxter Healthcare | $51.01 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $46.72 | 2024 | Arcalyst |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $42.31 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.05 | 2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $22.66 | 2025 | Assure Wcd |
| Cardiva Medical, INC. | $21.39 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $21.33 | 2025 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $18.15 | 2024 | |
| Catheter Precision INC. | $16.68 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $14.76 | 2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $13.71 | 2025 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bilal Saqi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.